ED BRON GP
- Product NDC
- 0485-0208
- 11-digit product format
- 004850208
- Labeler code
- 0485
- Product ID
- 0485-0208_423e6598-ff90-d9d4-e063-6294a90a1fba
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- GUAIFENESIN and PHENYLEPHRINE
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- EDWARDS PHARMACEUTICALS, INC.
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start
- 2012-06-01
- Substance
- GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
- Active strength
- 100; 5 mg/5mL; mg/5mL
- Pharmacologic classes
- Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ED BRON GP
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GUAIFENESIN | 100 mg/5mL |
| PHENYLEPHRINE HYDROCHLORIDE | 5 mg/5mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 495W7451VQ, 04JA59TNSJ |
| Rxcui | 1358627 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0485-0208-16 | ED BRON GP | 473 mL in 1 BOTTLE, PLASTIC | LIQUID | 473 | | 9 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| GUAIFENESIN | ACTIVE INGREDIENT | 495W7451VQ | ED BRON GP (GUAIFENESIN AND PHENYLEPHRINE) LIQUID [EDWARDS PHARMACEUTICALS, INC.] | 1 | |
| PHENYLEPHRINE | ACTIVE INGREDIENT | 1WS297W6MV | ED BRON GP (GUAIFENESIN AND PHENYLEPHRINE) LIQUID [EDWARDS PHARMACEUTICALS, INC.] | 1 | |
| GUAIFENESIN | ACTIVE MOIETY | 495W7451VQ | ED BRON GP (GUAIFENESIN AND PHENYLEPHRINE) LIQUID [EDWARDS PHARMACEUTICALS, INC.] | 1 | |
| PHENYLEPHRINE | ACTIVE MOIETY | 1WS297W6MV | ED BRON GP (GUAIFENESIN AND PHENYLEPHRINE) LIQUID [EDWARDS PHARMACEUTICALS, INC.] | 1 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | ED BRON GP (GUAIFENESIN AND PHENYLEPHRINE) LIQUID [EDWARDS PHARMACEUTICALS, INC.] | 1 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | ED BRON GP (GUAIFENESIN AND PHENYLEPHRINE) LIQUID [EDWARDS PHARMACEUTICALS, INC.] | 1 | |
| POTASSIUM CITRATE | INACTIVE INGREDIENT | EE90ONI6FF | ED BRON GP (GUAIFENESIN AND PHENYLEPHRINE) LIQUID [EDWARDS PHARMACEUTICALS, INC.] | 1 | |
| POTASSIUM SORBATE | INACTIVE INGREDIENT | 1VPU26JZZ4 | ED BRON GP (GUAIFENESIN AND PHENYLEPHRINE) LIQUID [EDWARDS PHARMACEUTICALS, INC.] | 1 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | ED BRON GP (GUAIFENESIN AND PHENYLEPHRINE) LIQUID [EDWARDS PHARMACEUTICALS, INC.] | 1 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | ED BRON GP (GUAIFENESIN AND PHENYLEPHRINE) LIQUID [EDWARDS PHARMACEUTICALS, INC.] | 1 | |
| SORBITOL | INACTIVE INGREDIENT | 506T60A25R | ED BRON GP (GUAIFENESIN AND PHENYLEPHRINE) LIQUID [EDWARDS PHARMACEUTICALS, INC.] | 1 | |
| SUCRALOSE | INACTIVE INGREDIENT | 96K6UQ3ZD4 | ED BRON GP (GUAIFENESIN AND PHENYLEPHRINE) LIQUID [EDWARDS PHARMACEUTICALS, INC.] | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | ED BRON GP (GUAIFENESIN AND PHENYLEPHRINE) LIQUID [EDWARDS PHARMACEUTICALS, INC.] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0485-0208 | ED BRON GP (GUAIFENESIN AND PHENYLEPHRINE) LIQUID [EDWARDS PHARMACEUTICALS, INC.] | 8 | Current NDC, Legacy NDC, 1 package rows | 20241228_b1fca5aa-d877-45e0-b074-dcbc6af94ee3.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0485-0208-16 | 00485020816 | 473 mL in 1 BOTTLE, PLASTIC (0485-0208-16) | 473 ml | 2012-06-01 | 0000-00-00 | No | No | Current |